AuntMinnie

Cash Bills

Curium to acquire Lantheus in $8 billion deal

The combined company would serve oncology, neurology, and cardiology patients across more than 70 countries.

Featured

A.) Rate of imaging utilization during surveillance by year, 2008 to 2022. B.) Rate of endoscopic ultrasound (EUS) and pancreatic surgery per 100 person years, 2008 to 2022.

Surveillance imaging doesn't improve pancreatic cancer survival

Emergency 400

ED patients prefer empathetic communication for incidental findings

Representative axial fused F-18 FDG-PET/MRI images and corresponding anatomic MRI images from a patient imaged at baseline and after initiation of androgen deprivation therapy are shown. Each row displays a distinct vascular territory. White arrows indicate focal areas of increased tracer uptake within the arterial wall, where spherical volumes of interest (VOIs) were placed for maximum standardized uptake value (SUVmax) measurement. Additional VOIs were placed in the superior vena cava and inferior vena cava for blood-pool activity sampling. SUVmax values from the arterial VOIs were extracted on the corresponding PET images and normalized to the blood-pool mean standardized uptake value to derive the maximum target-to-background ratio.

PET/MRI detects arterial inflammation in prostate cancer patients

July 31, 2026

Minnie Cast Thumbnail (17)

Women's Imaging MinnieCast, Episode 14: GLP-1s and breast cancer risk

July 31, 2026

Pacs Man Pontification

Podcast: The PACSMan Pontificates, Episode 4: The perfect PACS

July 30, 2026

Nongated CT scans can predict heart disease risk

July 30, 2026

Podcast: Testing the effectiveness of today's MR safety standard of care

More episodes »

Check out our Cases of the Week!

58-year-old woman with upper arm pain after a fall revisited

A 58-year-old woman with unknown medical history presented to the emergency department with a recent fall and left upper arm pain.

38-year-old woman with abdominal pain, missed period revisited

68-year-old woman with elevated calcium, parathyroid hormone revisited

A.) Rate of imaging utilization during surveillance by year, 2008 to 2022. B.) Rate of endoscopic ultrasound (EUS) and pancreatic surgery per 100 person years, 2008 to 2022.

Surveillance imaging doesn't improve pancreatic cancer survival

PET/MRI detects arterial inflammation in prostate cancer patients

Women's Imaging MinnieCast, Episode 14: GLP-1s and breast cancer risk

Nongated CT scans can predict heart disease risk

TACE plus thermal ablation improves survival in liver cancer

Deephealth White On Purple

DeepHealth lands FDA nod for breast ultrasound AI software

Radiologists can identify three out of four AI-generated images

Radiology dominates thirty years of FDA AI device approvals

Incorrect AI suggestions influence reader performance on mammography

Most patients want to know if AI being used for imaging reports

Acquisitions

RevealDx secures distribution deal, $3.4M investment from 4DMedical

GE HealthCare expands breast imaging portfolio

Curium to acquire Lantheus in $8 billion deal

Novartis secures expanded approval for Pluvicto

Siemens posts revenue gains in Q3

Emergency 400

ED patients prefer empathetic communication for incidental findings

Incorporating patient preferences into communication may improve understanding and follow-up in addressing incidental findings.

SNMMI issues analysis of 2027 HOPPS proposed rule

Beth Erickson elected president of ASTRO

More Practice Management

RevealDx secures distribution deal, $3.4M investment from 4DMedical

By AuntMinnie.com staff writers

Under the agreement, 4DMedical will distribute RevealAI-Lung in the U.S., Europe, Australia, and New Zealand.

August 3, 2026

GE HealthCare expands breast imaging portfolio

By AuntMinnie.com staff writers

The system expands the company's breast imaging portfolio with tools for supplemental screening of women with dense breasts and remote exam review.

August 3, 2026

GE HealthCare's new Invenia ABUS and ABUS StreamVue system.

Novartis secures expanded approval for Pluvicto

By AuntMinnie.com staff writers

Pluvicto can now be used as therapy in patients with PSMA-positive metastatic hormone-sensitive prostate cancer, in combination with an androgen receptor pathway inhibitor.

July 31, 2026

Prostate Imaging

Siemens posts revenue gains in Q3

By AuntMinnie.com staff writers

Growth was led by the vendor's Precision Therapy and Imaging units.

July 31, 2026

Siemens Rsna 2021 400

Ratio Therapeutics adds to coffers

By AuntMinnie.com staff writers

Both new and existing investors participated in the $70 million series C financing round.

July 31, 2026

DeepHealth lands FDA nod for breast ultrasound AI software

By AuntMinnie.com staff writers

The software automates lesion detection, characterization, and reporting, according to the RadNet subsidiary.

July 31, 2026

Deephealth White On Purple

Accuray to restructure debt, forge partnerships in turnaround plan

By AuntMinnie.com staff writers

Planned partners include Samsung HME America's NeuroLogica division and RaySearch Laboratories.

July 30, 2026

Hyperfine touts studies featuring Swoop system

By AuntMinnie.com staff writers

The studies showcase the Swoop system's uses in ambulatory and stroke care.

July 30, 2026

Hyperfine Swoop

Candelis gets FDA nod for ImageGrid StreamVue imaging platform

By AuntMinnie.com staff writers

ImageGrid StreamVue can be layered onto existing PACS environments.

July 30, 2026

Radiologist Breast Imaging Computer Screen

Median Technologies signs Canon Medical partnership for eyonis LCS

By AuntMinnie.com staff writers

Canon's subsidiary Olea Medical will leverage its CT imaging platform to support distribution of Median's software.

July 30, 2026

Business Handshake Intelligence 400 (1)

RadSite publishes clinical coverage guideline for breast CBCT imaging

By AuntMinnie.com staff writers

The guide outlines how breast CBCT should be used when conventional imaging approaches are inconclusive or inaccessible.

July 30, 2026

TACE plus thermal ablation improves survival in liver cancer

Median progression-free survival was 17.7 months with TACE-ablation versus 7.3 months with TACE alone.

July 30, 2026